IDEXX Computer Systems Acquires the Maker of DVMAX Veterinary Practice Management Software [Trade]
IDEXX will continue to support current users and develop DVMAX products
WESTBROOK, Maine, December 21, 2012—IDEXX Computer Systems announces that it has acquired Sneakers Software, Inc., New York, NY, maker of DVMAX Veterinary Practice Management Software and the DVMAX Research electronic medical records solution. DVMAX customers can look forward to continued support and development of both products by IDEXX, as well as improved integration with its diagnostic products and services. In addition, they also stand to benefit from IDEXX’s focus on improving the client experience before, during and after the patient visit.
“We’re pleased to have Sneakers Software join the IDEXX family, and we’re fully committed to supporting customers who have put their trust in DVMAX,” says Alexander Petersen, Vice President and General Manager, IDEXX Computer Systems. “IDEXX and Sneakers Software share a vision: to help veterinary practices run their business efficiently, eliminate missed charges and manage their day-to-day activities so they can concentrate on practicing medicine. Cementing this relationship with Sneakers Software is the finale to a very exciting year that also saw the release of Cornerstone version 8.3, including integrations with VetConnect PLUS and IDEXX Pet Health Network Pro, which will advance the practice of client-centered medicine.”
Paul Greenman, CEO of Sneakers Software, will join IDEXX to lead DVMAX product management, support and training as a new product line within IDEXX. “We’re excited about the future of DVMAX, and we believe that this new relationship with IDEXX is very positive news for our customers,” says Greenman. “IDEXX has a great track record of investing to innovate and improve the practice management experience of veterinary practices, and IDEXX will be helping DVMAX customers to benefit from these and future improvements.”
For more information on IDEXX Client and Practice Management products and services, visit idexx.com/clientandpracticemanagement or call 1-800-283-8386. Learn more about Sneakers Software or DVMAX at dvmax.com or by calling 1-800-877-9221.
About Sneakers Software
Sneakers Software Inc. (SSI) has over 20 years of product development in the business of veterinary medicine. Available for both Mac OS and Windows operating systems, the company’s powerful, easy-to-use DVMAX Veterinary Practice Management Software improves the overall quality of veterinary medicine and provides a solid return on investment for the practice.
About IDEXX Laboratories
IDEXX Laboratories, Inc. is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices. IDEXX is also a worldwide leader in providing livestock and poultry diagnostic tests and tests for the quality and safety of water and milk. Headquartered in Maine, IDEXX Laboratories employs more than 5,000 people and offers products to customers in over 100 countries.
Note Regarding Forward-looking Statements
This press release contains statements about the Company's business prospects for future periods that are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by the use of words such as "expects," "may," "anticipates," "intends," "would," "will," "plans," "believes," "estimates," "should," and similar words and expressions. These statements are based on management's expectations of future events as of the date of this press release, and the Company assumes no obligation to update any forward-looking statements as a result of new information or future events or developments. Actual results could differ materially from management's expectations. Factors that could cause or contribute to such differences include the following: the Company's ability to develop, manufacture, introduce and market new products and enhancements to existing products; the Company's ability to develop, manufacture, introduce and market new products and enhancements to existing products; the impact of a weak economy on demand for the Company's products and services; the effectiveness of the Company's sales and marketing activities; disruptions, shortages or pricing changes that affect the Company's purchases of products and materials from third parties, including from sole source suppliers; the Company's ability to manufacture complex biologic products; the effect of government regulation on the Company's business, including government decisions about whether and when to approve the Company's products and decisions regarding labeling, manufacturing and marketing products; changes or trends in veterinary medicine that affect the rate of use of the Company's products and services by veterinarians; the effects of operations outside the U.S., including from currency fluctuations, different regulatory, political and economic conditions, and different market conditions; and the effects of interruptions to the Company's operations due to natural disasters or system failures. A further description of these and other factors can be found in the Company's Annual Report on Form 10-K for the year ended December 31, 2011, and Quarterly Report on Form 10-Q for the quarter ended September 30, 2012, in the section captioned "Risk Factors."